← Eichor
Study identifier: NCT06652750 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices

Condition: Sick Sinus Syndrome · Atrioventricular Block, Second and Third Degree · Heart Failure  ·  Sponsor: The Third People's Hospital of Chengdu

PhaseNA
Planned participants688
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation. Participants will: undergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit

This description comes directly from the study's public registry record.

Talk to the study team

Lin Cai, master of medicine  ·  8619980510703  ·  clin63@yeah.net

Shiqiang Xiong, Doctor of Medicine(M.D.)  ·  8615377510703  ·  xionglliu@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

Sun Yat-sen Memorial HospitalGuangzhou, Guangdong, ChinaRecruiting
The Third People's Hospital of ChengduChengdu, Sichuan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06652750